‘Designer baby’ start-ups test limits of biotech taboo
AI Summary
Despite setbacks from failed ventures, the gene-editing sector continues to attract significant investor interest, pushing the boundaries of what's ethically and scientifically possible. These start-ups are exploring the controversial field of 'designer babies,' raising profound ethical questions about genetic modification. As the debate intensifies, the implications for future medical advancements and societal norms become increasingly significant, making this a pivotal moment for biotechnology and ethics.
Original Source
Read the full article at Ft →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.